BCDA
BCDA
NASDAQ · Biotechnology

Biocardia Inc

$1.25
+0.01 (+0.81%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.71M 1.55M 1.32M
Net Income 376.4K 361.3K 275.7K
EPS
Profit Margin 22.0% 23.4% 20.8%
Rev Growth +21.2% +15.5% +14.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.17M 5.65M 6.40M
Total Equity 5.11M 4.65M 5.00M
D/E Ratio 1.40 1.22 1.28
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 487.6K 534.5K 383.7K
Free Cash Flow 289.2K 193.8K 220.9K